AXONIS Therapeutics


AXONIS Therapeutics is advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders, in order to make a real difference for patients, their families, and the global healthcare system.

Industries

Employees

11-50

Links


Org chart

Joanna Stanicka
CEO & Founder
Collapse
Shane V. Hegarty
Chief Scientific Officer & Founder
Eilah Berlow
Business Operations Consultant
Linda Jones
Consultant Director of Translation
Mike Wiecek
Senior Director, Finance & Operations
Patrick J. Carew, MBA, FACHE, CFRE
Founder, Board Member & Chief Operating Officer (coo)

Board & advisors

Bob Yant
Director
Oswald Steward
Scientific Advisor
Lisa McKerracher
Scientific Advisor
James Guest
Scientific Advisor
Clifford Woolf
Scientific Advisor
Yves De Koninck
Scientific Advisor


Offices